Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients.
Cardiac valve calcification (VC) has long been regarded as a consequence of aging and abnormal calcium-phosphate metabolism in uremic patients. In view of the recent recognition of association among inflammation, malnutrition, and atherosclerosis, the possible role of inflammation and malnutrition in VC was investigated. Inflammatory markers (including C-reactive protein [CRP], fibrinogen, and basal metabolic rate) and nutritional status (assessed using serum albumin, subjective global nutrition assessment, and handgrip strength) were examined, in addition to calcium phosphate parameters and other traditional cardiovascular risk factors, including gender, smoking habits, BP, and lipid profile, in relation to VC in 137 patients who were on continuous ambulatory peritoneal dialysis. Compared with patients with no VC, patients with VC not only were older (60 [10] versus 54 [12] yr; P = 0.005), had higher plasma phosphate (1.89 [0.52] versus 1.64 [0.41] mmol/L; P = 0.003), and had higher parathyroid hormone (83 [40, 145] versus 38 [16, 71] pmol/L; P = 0.001) but also had higher CRP (4.5 [0.1, 13.4] versus 0.2 [0.1, 4.4] mg/L; P = 0.004), had higher fibrinogen (6.6 [1.9] versus 5.7 [1.3] g/L; P = 0.002), and had lower serum albumin (26 [4] versus 29 [3] g/L; P = 0004). Twenty-three percent of patients with VC versus 17% of patients with no VC were moderately to severely malnourished according to subjective global nutrition assessment (P = 0.05). Even after adjustment for patients' age, duration of continuous ambulatory peritoneal dialysis, diabetes, and calcium x phosphate product, cardiac VC remained strongly associated with CRP (odds ratio, 1.05; P = 0.026) and albumin (odds ratio, 0.85; P = 0.01). The data suggest that VC not only is a passive degenerative process but also involves active inflammation, similar to that seen in atherosclerosis. The presence of uncontrolled hyperphosphatemia and hyperparathyroidism further accelerates the progression of calcification. The data also indicate that VC and atherosclerosis should be considered as associated syndromes, sharing similar pathogenic mechanisms, namely active inflammation.
Wang
Angela Yee Moon
AYM
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Woo
Jean
J
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Wang
Mei
M
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Sea
Mandy Man Mei
MMM
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Ip
Ricky
R
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Li
Philip Kam Tao
PKT
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Lui
Siu Fai
SF
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
Sanderson
John Elsby
JE
Department of Medicine & Therapeutics, Center for Nutritional Studies, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong.
D000328:Adult; D000368:Aged; D002097:C-Reactive Protein / Q000032:analysis; D002114:Calcinosis / Q000097:blood / Q000150:complications*; D005260:Female; D006349:Heart Valve Diseases / Q000097:blood / Q000150:complications*; D006801:Humans; D007249:Inflammation / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009748:Nutrition Disorders / Q000150:complications*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D012709:Serum Albumin / Q000032:analysis
D012709:Serum Albumin; D002097:C-Reactive Protein